Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) Stock Overview
Explore Jagsonpal Pharmaceuticals Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
13.8B
P/E Ratio
33.47
EPS (TTM)
$6.31
ROE
0.17%
JAGSNPHARM.BO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.65, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $268.91.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 33.47 and a market capitalization of 13.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.